Related Experiment Video
Updated: Oct 21, 2025
15:23
Selection of Aptamers for Amyloid β-Protein, the Causative Agent of Alzheimer's Disease
Published on: May 13, 2010
19.6K
DNA-Based Smart Reagent for Detecting Alzheimer's Associated MicroRNAs
Arun Richard Chandrasekaran1, Ken Halvorsen1
1The RNA Institute, University of Albany, State University of New York, Albany, New York 12222, United States.
ACS Sensors
|September 7, 2021
Summary
Researchers developed a novel assay for detecting Alzheimer's disease (AD) microRNA biomarkers. This method offers sensitive, specific, and rapid detection of microRNAs without amplification, aiding AD diagnosis and research.
Area of Science:
- Biochemistry
- Molecular Biology
- Neuroscience
Background:
- Alzheimer's disease (AD) is a leading cause of neurodegeneration.
- MicroRNAs are increasingly recognized as key regulators and potential biomarkers in AD pathogenesis.
- Accurate detection of microRNAs is crucial for AD diagnosis and understanding disease progression.
Purpose of the Study:
- To introduce and validate the miRacles assay for single-step detection of AD-related microRNAs.
- To assess the sensitivity, specificity, and multiplexing capabilities of the miRacles assay.
- To screen for novel microRNA biomarkers associated with Alzheimer's disease in human brain samples.
Main Methods:
- Utilized the miRacles (microRNA activated conditional looping of engineered switches) assay for direct microRNA detection.
- Employed conformationally responsive DNA nanoswitches with electrophoretic readout.
- Validated the assay using the AD-related microRNA miR-107 and screened 56 microRNAs from human brain samples.
Main Results:
- Achieved high sensitivity (∼8 fM) and specificity for miR-107 detection among related microRNAs.
- Demonstrated simultaneous multiplexed detection of four microRNA targets.
- Identified four microRNAs showing differential expression between healthy and AD brain samples.
Conclusions:
- The miRacles assay provides a sensitive, specific, and amplification-free method for microRNA detection.
- This technology has potential for accelerating microRNA biomarker discovery in Alzheimer's disease.
- The assay shows promise as a diagnostic or monitoring tool for validated AD biomarkers.
